Optional Non-CME Satellite Presentations
Wednesday, April 29, 2026
12:00 – 1:00 PM EST
Ballroom A/B
IgA Nephropathy Update 2026
Jonathan Barratt, MD
Non-CME Satellite/Product Theatre presented by Calliditas.12:00 – 1:00 PM EST
Ballroom C
Reaching and Sustaining Remission: An Approach for Treating Severe Active GPA and MPA
Luis Alvarez, MD, PhD
Non-CME Satellite/Product Theatre presented by Amgen.
Thursday, April 30, 2026
7:30 – 8:15 AM EST
Ballroom A/B
VOYXACT® (sibeprenlimab-szsi) Prescribing Information Overview
Andrew E. Lazar, MD
View the invitation hereNon-CME Satellite/Product Theatre presented by Otsuka.
12:00 – 1:00 PM EST
Ballroom A/B
The Evolving IgAN Landscape: Navigating Treatment Options
Arvind Madan, MD
View the invitation hereNon-CME Satellite/Product Theatre presented by Novartis.
12:00 – 1:00 PM EST
Ballroom C
Guideline Considerations for Early Treatment of Lupus Nephritis
Mohammad Kamgar, MD
View the invitation hereNon-CME Satellite/Product Theatre presented by GlaxoSmithKline.
5:15 – 6:30 PM EST
Ballroom A/B
Overview of the Sibeprenlimab-szsi Clinical Program
Samir Parikh, MD, FASN
View the invitation hereNon-CME Satellite/Product Theatre presented by Otsuka.
Friday, May 1, 2026
7:30 – 8:15 AM EST
Ballroom A/B
Acthar Gel and Its Role in Treating Proteinuria Due to Primary Focal Segmental Glomerulosclerosis or Idiopathic Membranous Nephropathy
Abdul Ali Abdellatif, MD, FASN
Non-CME Satellite/Product Theatre presented by Keenova.
12:00 – 1:00 PM EST
Ballroom A/B
KERENDIA: At the Heart of Reducing CV Risks* in Adult Patients with CKD and T2D
Christian W. Mende, MD, FACP, FACN, FASN, FASH, FAHA
Non-CME Satellite/Product Theatre presented by Bayer.
12:00 – 1:00 PM EST
Ballroom C
EMPAVELI: C3G/Primary IC-MPGN
Prince Anand, MD, FACP
Non-CME Satellite/Product Theatre presented by Apellis.
These programs are developed and offered by industry supporters. They are not official programs of Cleveland Clinic.